Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 25

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 25
---
 issuance date, at the time of exercise, there is no effective registration statement registering with a current prospectus
available for resale of the Depositary Shares underlying the February Placement Agent Warrants.

Exercise Price.The exercise price of a portion of the February Placement Agent Warrants are $10,000.00 per Depositary Share and another portion
is $5,800.00 per Depositary Share, respectively, each subject to the ‘cashless exercise’ arrangements described above and
to adjustment as described herein.

Beneficial Ownership Limitation. A holder shall have no right to exercise any portion of a February Placement Agent Warrant, to the extent that,
after giving effect to such exercise, such holder, together with such holder’s affiliates, and any persons acting as a group together
with such holder or any such affiliate, would beneficially own in excess of 4.99% of the number of Ordinary Shares outstanding immediately
after giving effect to the issuance of the Ordinary Shares underlying the Depositary Shares upon such exercise. The holder of such warrant,
upon notice to us, may increase or decrease the beneficial ownership limitation to a percentage not to exceed 9.99%, provided that any
increase in the beneficial ownership limitation shall not be effective until 61 days following notice to us. Beneficial ownership of the
holder and its affiliates will be determined in accordance with Section 13(d) of the Exchange Act, and the rules and regulations promulgated
thereunder.

Stock dividends and stock splits. If we pay a stock dividend or otherwise make a distribution payable in Depositary Shares or Ordinary Shares,
or any other equity or equivalent securities, subdivide or combine outstanding Depositary Shares or Ordinary Shares, or reclassify Depositary
Shares, Ordinary Shares or any shares of our capital stock, the exercise price of each February Placement Agent Warrant will be adjusted
by multiplying the then exercise price by a fraction, the numerator of which shall be the number of Depositary Shares (excluding treasury
shares, if any) outstanding immediately before such event, and the denominator of which shall be the number of Depositary Shares outstanding
immediately after such event.

Rights Offerings; pro rata distributions. If we issue Ordinary Share equivalents or rights to purchase shares, warrants, securities or other
property pro rata to holders of Depositary Shares, a holder of a February Placement Agent Warrant will be entitled to acquire, subject
to the beneficial ownership limitation described above, such securities or property that such holder could have acquired if such holder
had held the